S 1287
117th Congress
Senate
Health
Civil actions and liability
Congressional oversight
Government trust funds
Health care costs and insurance
Health programs administration and funding
Manufacturing
Medicare
Prescription drugs
REFUND Act of 2021
Introduced: April 21, 2021
Introduced by:
Durbin, Richard J.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 21, 2021
Read twice and referred to the Committee on Finance. (text: CR S2126-2127)
Apr 21, 2021
Introduced in Senate
Plain-English summary
Recovering Excessive Funds for Unused and Needless Drugs Act of 2021 or the REFUND Act of 2021
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties.
The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)
What's happening now
Read twice and referred to the Committee on Finance. (text: CR S2126-2127)
Committees of jurisdiction
1